Trendlines Medical Singapore

SINGAPORE (Feb 8): Trendlines Medical Singapore, a subsidiary of Israeli company The Trendlines Group, is partnering Singapore-based investor Ozi Amanat’s venture capital firm, K2 Global, to collaborate in SPRING SEEDS Capital’s (SSC) $100 million inv

SINGAPORE (Nov 9): The Trendlines Group saw its earnings for 3Q17 nearly double to US$3 million ($4.1 million) from US$1.6 million a year ago on higher total income due to fair value gains.

SINGAPORE (Oct 16): Trendlines Medical Singapore, a 76.43%-owned subsidiary of Catalist-listed Israeli company The Trendlines Group, has made its first investment by committing a total of US$60,000 ($81,150) to a medical device start-up, InterVaal.

SINGAPORE (April 11): Trendlines Group, the incubator for medical and agri-tech companies, aims to increase its number of portfolio companies, build value in these companies, expand into new markets as well as grow Trendlines Labs.

SINGAPORE (Feb 1): Trendlines Medical Singapore, the medical incubator subsidiary of Israeli firm Trendlines Group, will hold its official opening ceremony on Feb 22 at its office located at Launchpad @One North.

SINGAPORE (Jan 16): Trendlines Medical Singapore, the medical incubator subsidiary of Israeli firm Trendlines Group, will receive a grant of up to $2.2 million under SPRING Singapore’s Incubator Development Program.

SINGAPORE (Dec 21): Trendlines Group has entered an agreement with B. Braun, the German medical device company, for the latter to become a 20.74% minority shareholder in the group’s wholly-owned subsidiary, Trendlines Medical Singapore.